Virtus ETF Advisers’s ResMed RMD Stock Holding History

Virtus ETF Advisers’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.96K	Hold	31	–	–	﹤0.01%	463
2025 Q4	$7.47K	Hold	31	–	–	﹤0.01%	460
2025 Q3	$8.49K	Sell	31 -269	-90%	-$73.5K	﹤0.01%	434
2025 Q2	$77.4K	Hold	300	–	–	0.05%	329
2025 Q1	$67.2K	Sell	300 -4,361	-94%	-$1.02M	0.04%	327
2024 Q4	$1.07M	Buy	+4,661	New	+$1.12M	0.44%	109
2023 Q3	–	Sell	-3,441	Closed	-$752K	–	473
2023 Q2	$752K	Buy	+3,441	New	+$767K	0.45%	87
2023 Q1	–	Sell	-3,473	Closed	-$723K	–	480
2022 Q4	$723K	Buy	+3,473	New	+$763K	0.38%	114
2022 Q3	–	Sell	-3,147	Closed	-$660K	–	466
2022 Q2	$660K	Buy	+3,147	New	+$670K	0.24%	154

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtus ETF Advisers's RMD Position: Q1 2026 in Review

Virtus ETF Advisers held its ResMed (RMD) position steady in Q1 2026 at 31 shares worth $6.96K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Virtus ETF Advisers first reported a position in RMD in Q2 2022 and has held it in 9 quarters since. The position peaked at $1.07M in Q4 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Virtus ETF Advisers held 31 shares of ResMed worth $6.96K as of Q1 2026.
Virtus ETF Advisers left its ResMed share count unchanged in Q1 2026.
ResMed made up ﹤0.01% of Virtus ETF Advisers's portfolio in Q1 2026, its #463 holding.
Virtus ETF Advisers first reported a position in ResMed in Q2 2022 and has held it in 9 quarters since.
Virtus ETF Advisers's ResMed position peaked at $1.07M in Q4 2024.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Virtus ETF Advisers's 13F filing for Q1 2026, filed 14 May 2026.